IOVS Am. J. Pathology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Derevjanik, N. L.
Right arrow Articles by Campochiaro, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derevjanik, N. L.
Right arrow Articles by Campochiaro, P. A.
(Investigative Ophthalmology and Visual Science. 2002;43:2462-2467.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Quantitative Assessment of the Integrity of the Blood–Retinal Barrier in Mice

Nancy L. Derevjanik, Stanley A. Vinores, Wei-Hong Xiao, Keisuke Mori, Tara Turon, Tyler Hudish, Steve Dong and Peter A. Campochiaro

From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

PURPOSE. The purpose of this study was to develop and characterize a quantitative assay of blood–retinal barrier (BRB) function in mice and to determine the effect of several purported vasopermeability factors on the BRB.

METHODS. Adult C57BL/6J mice were treated with three regimens of increasingly extensive retinal cryopexy and subsequently were given an intraperitoneal injection of 1 µCi/g body weight of [3H]mannitol. At several time points, the amount of radioactivity per milligram tissue was compared in retina, lung, and kidney. Time points that maximize signal-to-background differential in the retina were identified, and the ratio of counts per minute (CPM) per milligram retina to CPM per milligram lung (retina-to-lung leakage ratio, RLLR) or kidney (retina-to-renal leakage ratio, RRLR) were calculated. This technique was then used to compare the amount of BRB breakdown that occurs after intravitreous injection of vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF)-1, prostaglandin (PG) E1, PGE2, interleukin (IL)-1ß, or tumor necrosis factor (TNF)-{alpha}.

RESULTS. Twenty-four hours after retinal cryopexy, there was a higher level of radioactivity in treated than in control retinas, and the signal-to-background difference was optimal when measurements were obtained 1 hour after injection of [3H]mannitol. In untreated mice, the RLLR was 0.30 ± 0.02 and the RRLR was 0.22 ± 0.01. Twenty-four hours after one 5-second application of retinal cryopexy, the RLLR was 0.73 ± 0.20 and the RRLR was 0.71 ± 0.23. With increasing amounts of cryopexy, there was an increase in the RLLR and RRLR, so that after two 10-second applications, the RLLR was 1.66 ± 0.31 and the RRLR was 1.47 ± 0.20. Intravitreous injection of VEGF, IGF-1, PGE1, PGE2, IL-1ß, or TNF-{alpha} each caused significant increases in the RLLR and RRLR, but there were some differences in potency and time course. VEGF caused prominent BRB breakdown at 6 hours that returned to near normal by 24 hours. IL-1ß also caused relatively rapid breakdown of the BRB, but its effect was more prolonged than that caused by VEGF. There was delayed, but substantial breakdown of the BRB after injection of TNF-{alpha}. IGF-1, PGE2, and PGE1 caused less severe, relatively delayed, and more prolonged BRB breakdown.

CONCLUSIONS. Measurement of the RLLR or RRLR after intraperitoneal injection of [3H]mannitol in mice provides a quantitative assessment of BRB function that is normalized and can therefore be compared from assay to assay. Comparison of the extent and duration of BRB breakdown after intravitreous injection of vasoactive substances shows that agents can be grouped by resultant extent and time course of leakage. Additional studies are needed to determine whether this grouping has its basis in shared mechanisms of BRB disruption.




This article has been cited by other articles:


Home page
IOVSHome page
M. Rehak, M. Hollborn, I. Iandiev, T. Pannicke, A. Karl, A. Wurm, L. Kohen, A. Reichenbach, P. Wiedemann, and A. Bringmann
Retinal Gene Expression and Muller Cell Responses after Branch Retinal Vein Occlusion in the Rat
Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2359 - 2367.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
D V Do, Q D Nguyen, S M Shah, D J Browning, J A Haller, K Chu, K Yang, J M Cedarbaum, R L Vitti, A Ingerman, et al.
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema
Br. J. Ophthalmol., February 1, 2009; 93(2): 144 - 149.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. T. Ramadan, A. L. Moyer, and M. C. Callegan
A Role for Tumor Necrosis Factor-{alpha} in Experimental Bacillus cereus Endophthalmitis Pathogenesis
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4482 - 4489.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Simo, E. Carrasco, A. Fonollosa, J. Garcia-Arumi, R. Casamitjana, and C. Hernandez
Deficit of Somatostatin in the Vitreous Fluid of Patients With Diabetic Macular Edema
Diabetes Care, March 1, 2007; 30(3): 725 - 727.
[Full Text] [PDF]


Home page
Diabetes CareHome page
C. Hernandez, A. Fonollosa, M. Garcia-Ramirez, M. Higuera, R. Catalan, A. Miralles, J. Garcia-Arumi, and R. Simo
Erythropoietin Is Expressed in the Human Retina and It Is Highly Elevated in the Vitreous Fluid of Patients With Diabetic Macular Edema.
Diabetes Care, September 1, 2006; 29(9): 2028 - 2033.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. C. Amrite, S. P. Ayalasomayajula, N. P. S. Cheruvu, and U. B. Kompella
Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE2, VEGF, and Vascular Leakage.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1149 - 1160.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Uckermann, F. Kutzera, A. Wolf, T. Pannicke, A. Reichenbach, P. Wiedemann, S. Wolf, and A. Bringmann
The Glucocorticoid Triamcinolone Acetonide Inhibits Osmotic Swelling of Retinal Glial Cells via Stimulation of Endogenous Adenosine Signaling
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1036 - 1045.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. A. Berkowitz, R. Roberts, H. Luan, J. Peysakhov, X. Mao, and K. A. Thomas
Dynamic Contrast-Enhanced MRI Measurements of Passive Permeability through Blood Retinal Barrier in Diabetic Rats
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2391 - 2398.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Liu, J.-G. Ren, W. L. Cooper, C. E. Hawkins, M. R. Cowan, and P. Y. Tong
Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site
PNAS, April 27, 2004; 101(17): 6605 - 6610.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. A. Campochiaro
Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 922 - 931.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. Hou, S.-W. You, M.-M. Wu, F. Kuang, H.-L. Liu, X.-Y. Jiao, and G. Ju
Neuroprotective Effect of Inosine on Axotomized Retinal Ganglion Cells in Adult Rats
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 662 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. F. H. M. Boonman, G. J. D. van Mierlo, M. F. Fransen, K. L. M. C. Franken, R. Offringa, C. J. M. Melief, M. J. Jager, and R. E. M. Toes
Intraocular Tumor Antigen Drains Specifically to Submandibular Lymph Nodes, Resulting in an Abortive Cytotoxic T Cell Reaction
J. Immunol., February 1, 2004; 172(3): 1567 - 1574.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology